Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy.

Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marinò M.

JAMA Ophthalmol. 2018 Jun 1;136(6):613-619. doi: 10.1001/jamaophthalmol.2018.0806.

PMID:
29710102
2.

Thyroid dysfunctions secondary to cancer immunotherapy.

Chalan P, Di Dalmazi G, Pani F, De Remigis A, Corsello A, Caturegli P.

J Endocrinol Invest. 2018 Jun;41(6):625-638. doi: 10.1007/s40618-017-0778-8. Epub 2017 Dec 13. Review.

3.

Walter E. Dandy: his contributions to pituitary surgery in the context of the overall Johns Hopkins Hospital experience.

Corsello A, Di Dalmazi G, Pani F, Chalan P, Salvatori R, Caturegli P.

Pituitary. 2017 Dec;20(6):683-691. doi: 10.1007/s11102-017-0834-6.

4.

Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.

Lupi I, Cosottini M, Caturegli P, Manetti L, Urbani C, Cappellani D, Scattina I, Martino E, Marcocci C, Bogazzi F.

Eur J Endocrinol. 2017 Aug;177(2):127-135. doi: 10.1530/EJE-17-0123.

PMID:
28626085
5.

In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis.

Lin HH, Gutenberg A, Chen TY, Tsai NM, Lee CJ, Cheng YC, Cheng WH, Tzou YM, Caturegli P, Tzou SC.

Sci Rep. 2017 Mar 6;7:43492. doi: 10.1038/srep43492.

6.

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD.

Thyroid. 2017 Apr;27(4):481-483. doi: 10.1089/thy.2016.0628. Epub 2017 Feb 21. Review.

PMID:
28114862
7.

Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis.

Iwata N, Iwama S, Sugimura Y, Yasuda Y, Nakashima K, Takeuchi S, Hagiwara D, Ito Y, Suga H, Goto M, Banno R, Caturegli P, Koike T, Oshida Y, Arima H.

Pituitary. 2017 Jun;20(3):301-310. doi: 10.1007/s11102-016-0780-8.

PMID:
27896569
8.

Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

Caturegli P, Di Dalmazi G, Lombardi M, Grosso F, Larman HB, Larman T, Taverna G, Cosottini M, Lupi I.

Am J Pathol. 2016 Dec;186(12):3225-3235. doi: 10.1016/j.ajpath.2016.08.020. Epub 2016 Oct 15.

9.

Reactive oxygen species in organ-specific autoimmunity.

Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P.

Auto Immun Highlights. 2016 Dec;7(1):11. doi: 10.1007/s13317-016-0083-0. Epub 2016 Aug 4.

10.

Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome.

Pollock AJ, Seibert TS, Salvatori C, Caturegli P, Allen DB.

Horm Res Paediatr. 2017;87(2):123-129. doi: 10.1159/000446912. Epub 2016 Jun 30.

11.

Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.

Sharma R, Di Dalmazi G, Caturegli P.

Thyroid. 2016 Aug;26(8):1117-24. doi: 10.1089/thy.2016.0092. Epub 2016 Jul 22.

12.

A Subset of Men With Age-Related Decline in Testosterone Have Gonadotroph Autoantibodies.

Ricciuti A, Travison TG, Di Dalmazi G, Talor MV, DeVincentiis L, Manley RW, Bhasin S, Caturegli P, Basaria S.

J Clin Endocrinol Metab. 2016 Apr;101(4):1535-41. doi: 10.1210/jc.2016-1016. Epub 2016 Mar 10.

13.

Disease prevalence in a rural Andean population of central Peru: a focus on autoimmune and allergic diseases.

Caturegli G, Caturegli P.

Auto Immun Highlights. 2016 Dec;7(1):3. doi: 10.1007/s13317-016-0076-z. Epub 2016 Feb 10.

14.

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells.

Kimura H, Caturegli P, Takahashi M, Suzuki K.

J Immunol Res. 2015;2015:541984. doi: 10.1155/2015/541984. Epub 2015 Oct 8. Review.

15.

Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders.

Kimura H, Usui F, Karasawa T, Kawashima A, Shirasuna K, Inoue Y, Komada T, Kobayashi M, Mizushina Y, Kasahara T, Suzuki K, Iwasaki Y, Yada T, Caturegli P, Takahashi M.

Sci Rep. 2015 Oct 30;5:15883. doi: 10.1038/srep15883.

16.

Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.

Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, Suzuki H, Iwata N, Takeuchi S, Nakashima K, Takagi H, Izumida H, Ochiai H, Fujisawa H, Suga H, Arima H, Shimoyama Y, Takahashi M, Nishioka H, Ishikawa SE, Shimatsu A, Caturegli P, Oiso Y.

J Clin Endocrinol Metab. 2015 Jul;100(7):E946-54. doi: 10.1210/jc.2014-4209. Epub 2015 Apr 28.

17.

The Pathology Residency Program of the Johns Hopkins University School of Medicine: a model of its kind.

Caturegli P, McCarthy EF, Jackson JB, Hruban RH.

Arch Pathol Lab Med. 2015 Mar;139(3):400-6. doi: 10.5858/arpa.2013-0629-HP.

PMID:
25724037
18.

Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.

Xu C, Ricciuti A, Caturegli P, Keene CD, Kargi AY.

Pituitary. 2015 Aug;18(4):441-7. doi: 10.1007/s11102-014-0592-7.

PMID:
25224140
19.

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.

De Remigis A, de Gruijl TD, Uram JN, Tzou SC, Iwama S, Talor MV, Armstrong TD, Santegoets SJ, Slovin SF, Zheng L, Laheru DA, Jaffee EM, Gerritsen WR, van den Eertwegh AJ, Le DT, Caturegli P.

Int J Cancer. 2015 Jan 1;136(1):127-37. doi: 10.1002/ijc.28973. Epub 2014 May 28.

20.

Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel.

McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S.

JAMA. 2014 Apr 16;311(15):1563-5. doi: 10.1001/jama.2013.285606. No abstract available.

PMID:
24737370
21.

Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.

Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P.

Sci Transl Med. 2014 Apr 2;6(230):230ra45. doi: 10.1126/scitranslmed.3008002.

22.

Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases.

Ricciuti A, De Remigis A, Landek-Salgado MA, De Vincentiis L, Guaraldi F, Lupi I, Iwama S, Wand GS, Salvatori R, Caturegli P.

J Clin Endocrinol Metab. 2014 May;99(5):1758-66. doi: 10.1210/jc.2014-1049. Epub 2014 Feb 25.

23.

Hashimoto thyroiditis: clinical and diagnostic criteria.

Caturegli P, De Remigis A, Rose NR.

Autoimmun Rev. 2014 Apr-May;13(4-5):391-7. doi: 10.1016/j.autrev.2014.01.007. Epub 2014 Jan 13. Review.

PMID:
24434360
24.

Clinical features of sellar and suprasellar meningiomas.

Kwancharoen R, Blitz AM, Tavares F, Caturegli P, Gallia GL, Salvatori R.

Pituitary. 2014 Aug;17(4):342-8. doi: 10.1007/s11102-013-0507-z.

PMID:
23975080
25.

Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells.

Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P.

J Clin Endocrinol Metab. 2013 Oct;98(10):3920-5. doi: 10.1210/jc.2013-2411. Epub 2013 Aug 12. Erratum in: J Clin Endocrinol Metab. 2013 Dec;98(12):4992.

26.

From Japan with love: another tessera in the hypophysitis mosaic.

Caturegli P, Iwama S.

J Clin Endocrinol Metab. 2013 May;98(5):1865-8. doi: 10.1210/jc.2013-1912. No abstract available.

PMID:
23650339
27.

Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders.

Lupi I, Raffaelli V, Di Cianni G, Caturegli P, Manetti L, Ciccarone AM, Bogazzi F, Mariotti S, Del Prato S, Martino E.

J Endocrinol Invest. 2013 Feb;36(2):127-31.

PMID:
23481612
28.

Use of a clinicoradiological score to determine the presurgical diagnosis of autoimmune hypophysitis in a teenage girl.

Bose V, Caturegli P, Conrad J, Omran W, Boor S, Giese A, Gutenberg A.

J Neurosurg Pediatr. 2013 Mar;11(3):335-9. doi: 10.3171/2012.11.PEDS12432. Epub 2013 Jan 4.

PMID:
23289917
29.

Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records.

Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S.

Thyroid. 2013 Feb;23(2):142-50. doi: 10.1089/thy.2012.0554.

30.

Relationship between monoclonal gammopathy and cardiac amyloid type.

Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK.

Cardiovasc Pathol. 2013 May-Jun;22(3):189-94. doi: 10.1016/j.carpath.2012.09.001. Epub 2012 Oct 24.

PMID:
23102805
31.

Anatabine ameliorates experimental autoimmune thyroiditis.

Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou SC, Ladenson PW.

Endocrinology. 2012 Sep;153(9):4580-7. doi: 10.1210/en.2012-1452. Epub 2012 Jul 17.

PMID:
22807490
32.

Hürthle cells predict hypothyroidism in interferon-γ transgenic mice of different genetic backgrounds.

Iwama S, De Remigis A, Bishop JA, Kimura HJ, Caturegli P.

Endocrinology. 2012 Aug;153(8):4059-66. doi: 10.1210/en.2012-1236. Epub 2012 Jun 19.

33.

LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.

Zheng G, Chaux A, Sharma R, Netto G, Caturegli P.

Exp Mol Pathol. 2013 Feb;94(1):29-32. doi: 10.1016/j.yexmp.2012.05.008. Epub 2012 Jun 12.

34.

Autoimmune hypophysitis: autoantigens and association with CTLA-4 blockade.

Caturegli P.

Ann Endocrinol (Paris). 2012 Apr;73(2):78. doi: 10.1016/j.ando.2012.04.006. Epub 2012 Apr 25. No abstract available.

PMID:
22537512
35.

Pituitary antibodies in women with Hashimoto's thyroiditis: prevalence in diagnostic and prediagnostic sera.

Guaraldi F, Landek-Salgado MA, Hutfless S, Samoni F, Talor MV, Matos PG, Salvatori R, Rose NR, Caturegli P.

Thyroid. 2012 May;22(5):509-15. doi: 10.1089/thy.2011.0373. Epub 2012 Apr 2.

36.

Johns Hopkins Hospital notables portrayed on philatelic material.

Guaraldi F, Gori D, Hruban R, Caturegli P.

J Med Biogr. 2011 Nov;19(4):161-7. doi: 10.1258/jmb.2011.011036.

PMID:
22319189
37.

Macrophages participate in IL-17-mediated inflammation.

Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Quader F, Chen P, Zheng D, Caturegli P, Rose NR, Ciháková D.

Eur J Immunol. 2012 Mar;42(3):726-36. doi: 10.1002/eji.201141737. Epub 2012 Jan 23.

38.

Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis.

Barbesino G, Sluss PM, Caturegli P.

J Clin Endocrinol Metab. 2012 Feb;97(2):345-50. doi: 10.1210/jc.2011-1591. Epub 2011 Nov 16.

39.

Prevalence of antipituitary antibodies in acromegaly.

Guaraldi F, Caturegli P, Salvatori R.

Pituitary. 2012 Dec;15(4):490-4. doi: 10.1007/s11102-011-0355-7.

PMID:
22002711
40.

γ/IgG ratio: role in distinguishing monoclonal spikes from fibrinogen.

Lee MT, Caturegli P, Humphrey RL, Thompson RE, Detrick B.

J Clin Lab Anal. 2011;25(5):332-6. doi: 10.1002/jcla.20480.

PMID:
21919067
41.

From pituitary expansion to empty sella: disease progression in a mouse model of autoimmune hypophysitis.

Lupi I, Zhang J, Gutenberg A, Landek-Salgado M, Tzou SC, Mori S, Caturegli P.

Endocrinology. 2011 Nov;152(11):4190-8. doi: 10.1210/en.2011-1004. Epub 2011 Aug 23.

42.

Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis.

Landek-Salgado MA, Leporati P, Lupi I, Geis A, Caturegli P.

Pituitary. 2012 Sep;15(3):412-9. doi: 10.1007/s11102-011-0338-8.

PMID:
21861119
43.

Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1.

Landek-Salgado MA, Rose NR, Caturegli P.

J Autoimmun. 2012 May;38(2-3):J88-96. doi: 10.1016/j.jaut.2011.07.001. Epub 2011 Jul 23.

44.

Diagnosis and treatment of autoimmune hypophysitis: a short review.

Lupi I, Manetti L, Raffaelli V, Lombardi M, Cosottini M, Iannelli A, Basolo F, Proietti A, Bogazzi F, Caturegli P, Martino E.

J Endocrinol Invest. 2011 Sep;34(8):e245-52. doi: 10.3275/7863. Epub 2011 Jul 12. Review.

PMID:
21750396
45.

Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.

Xiao Z, Mohamood AS, Uddin S, Gutfreund R, Nakata C, Marshall A, Kimura H, Caturegli P, Womer KL, Huang Y, Jie C, Chakravarti S, Schneck JP, Yagita H, Hamad AR.

Am J Pathol. 2011 Aug;179(2):725-32. doi: 10.1016/j.ajpath.2011.04.016. Epub 2011 Jun 15.

46.

Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease.

Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1466-71. doi: 10.1210/jc.2011-0228. Epub 2011 Jun 29.

47.

Pituitary autoimmunity is associated with hypopituitarism in patients with primary empty sella.

Lupi I, Manetti L, Raffaelli V, Grasso L, Sardella C, Cosottini M, Iannelli A, Gasperi M, Bogazzi F, Caturegli P, Martino E.

J Endocrinol Invest. 2011 Sep;34(8):e240-4. doi: 10.3275/7758. Epub 2011 May 27.

PMID:
21623153
48.

Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.

Sharma RB, Fan X, Caturegli P, Rose NR, Burek CL.

J Thyroid Res. 2011;2011:895923. doi: 10.4061/2011/895923. Epub 2011 Apr 10.

49.

IgG4-related hypophysitis: a new addition to the hypophysitis spectrum.

Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P.

J Clin Endocrinol Metab. 2011 Jul;96(7):1971-80. doi: 10.1210/jc.2010-2970. Epub 2011 May 18.

50.

Necrotizing infundibulo-hypophysitis: an entity too rare to be true?

Gutenberg A, Caturegli P, Metz I, Martinez R, Mohr A, Brück W, Rohde V.

Pituitary. 2012 Jun;15(2):202-8. doi: 10.1007/s11102-011-0307-2.

Supplemental Content

Loading ...
Support Center